Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Kidney Int Rep
Prif Awduron: Ainley, Louise, Law, Steven, Heptinstall, Lauren, Rodriguez-Justo, Manuel, Thomson, Kirsty, Pepper, Ruth J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2020
Pynciau:
Nephrology Rounds
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783564/
https://ncbi.nlm.nih.gov/pubmed/33426402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.10.012
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg